Summary - LBRX - NASDAQ - Weiss Ratings

E

LB Pharmaceuticals Inc LBRX

$23.34 -$1.01-4.15% NASDAQ

Recommendation

Dividend Power Score

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$13.36 - $24.95

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

HealthTech & Bioinformatics Biotechnology Health Care Pharmaceutical

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Yield Index

Headlines

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

2/10/2026 - Globe Newswire

LB Pharmaceuticals (NASDAQ:LBRX) Sets New 52-Week High - Time to Buy?

2/5/2026 - MarketBeat

LB Pharmaceuticals stock rises on $100M financing

2/5/2026 - SeekingAlpha.com: All News

LB Pharmaceuticals stock rises on $100M financing

2/5/2026 - Seeking Alpha - Healthcare

LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement

2/5/2026 - TipRanks Financial Blog

LB Pharmaceuticals prices 3.31M shares at $21.17 in private placement

2/5/2026 - The Fly

LB Pharmaceuticals Announces $100.0 Million Private Placement

2/5/2026 - Globe Newswire

LB Pharmaceuticals Advances LB-102 Into Long-Term Phase 3 Safety Study for Schizophrenia

1/27/2026 - TipRanks Financial Blog

LB Pharmaceuticals (NASDAQ:LBRX) Shares Down 6.4% - Time to Sell?

1/26/2026 - MarketBeat

LB Pharmaceuticals (LBRX) Launches Phase 2 Trial for Bipolar Depression Treatment

1/26/2026 - GuruFocus

LB Pharmaceuticals initiates Phase 2 trial of LB-102

1/26/2026 - The Fly

LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 ...

1/26/2026 - GuruFocus

LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program

1/26/2026 - Globe Newswire

LB Pharmaceuticals (NASDAQ:LBRX) Hits New 52-Week High - What's Next?

1/22/2026 - MarketBeat

LB Pharmaceuticals (NASDAQ:LBRX) Hits New 52-Week High - What's Next?

1/22/2026 - Ticker Report

LB Pharmaceuticals appoints Pazdera as General Counsel

1/21/2026 - The Fly

LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel

1/21/2026 - GuruFocus

LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel

1/21/2026 - Globe Newswire

LB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Rating of "Moderate Buy" from Brokerages

1/17/2026 - MarketBeat

LB Pharmaceuticals (NASDAQ:LBRX) Trading Down 5.5% - What's Next?

1/16/2026 - MarketBeat

LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Up 7.7% - Time to Buy?

1/15/2026 - MarketBeat

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

1/12/2026 - GuruFocus

LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

1/12/2026 - Globe Newswire

LB Pharmaceuticals (NASDAQ:LBRX) Upgraded by Roth Capital to "Strong-Buy" Rating

1/10/2026 - Ticker Report

LB Pharmaceuticals (NASDAQ:LBRX) Stock Rating Upgraded by Roth Capital

1/10/2026 - MarketBeat

Income Statement

Total Revenue (TTM)

--

EBITDA (TTM)

--

EBIT (TTM)

--

Net Income (TTM)

--

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

--

Cash from Investing (TTM)

--

Cash from Financing (TTM)

--

Net Change in Cash (TTM)

--

Filings

Filing Date

Thursday, November 6, 2025

Period Date

Tuesday, September 30, 2025

Next Filing

Week of Aug 17 and 21 (est)

Price History

Loading...

Beta

--

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

--

2-Year Total Return

--

3-Year Total Return

--

5-Year Total Return

--

52-week Low

Sep 26, 2025 - $13.36

52-week High

Feb 05, 2026 - $24.95

Valuation

Market Cap

$616.03M - Small Cap

Enterprise Value

Price/Sales (TTM)

--

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

212 605 0300

Address

One Pennsylvania Plaza
New York, NY 10119

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead... more